The TEPEZZA OBI trial evaluated the safety and efficacy of SC teprotumumab in patients with active TED and proptosis of 3mm or greater from baseline.
Debates over how geometry is understood and learned date back at least to the days of Plato, with more recent scholars ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results